Skip to main content
. 2021 Mar 18;65(4):e02577-20. doi: 10.1128/AAC.02577-20

FIG 3.

FIG 3

Screening and IC50 measurements of the 3CLpro inhibitors. (A to C) The IC50 values of FDA-approved drugs, tolcapone, levothyroxine, and manidipine-2HCl, were measured to be 7.9 ± 0.9, 19.2 ± 1.2, and 10.4 ± 1.6, respectively, based on the inhibitor concentration-dependent curves.